Broken String Biosciences, a biotechnology company enabling gene editing teams to accelerate development of safer, more effective genetic medicines, has launched BaseMap ABE. Built on the company’s INDUCE-seq technology, BaseMap ABE extends the platform’s capabilities to support adenine base editing (ABE) applications. Base editing is rapidly gaining momentum as a… Read More
Broken String Biosciences has appointed Bruce Eaton as Chairman of the Board. The appointment from the biotechnology company allows it to drive the global commercialisation of its INDUCE-seq platform, which it says can provide rapid, unbiased, genome-wide measurement of on- and off-target DNA breaks directly in customers’ own… Read More
Biotechnology company Broken String Biosciences has rebranded as the company repositions its strategic focus. The company will now support early discovery programmes through to investigational new drug (IND)-enabling studies, moving away from its focus on being a specialist technology provider. Broken String Biosciences, a company… Read More
Broken String Biosciences has entered a research collaboration with the Francis Crick Institute, focused on leveraging technology to investigate the impact of genomic instability in the development of amyotrophic lateral sclerosis (ALS). The aim to achieve this is through the development of novel applications for Broken String’s… Read More
